Literature DB >> 7812701

Pulmonary infections in lung cancer patients at diagnosis.

S Putinati1, L Trevisani, M Gualandi, G Guerra, M R Rossi, S Sartori, A Potena.   

Abstract

We carried out a prospective study involving 96 consecutive lung cancer patients at diagnosis, in order to determine through quantitative cultures of the bronchoalveolar lavage (BAL) fluid, the prevalence of pulmonary infections; we also evaluated the relationship between a patient's performance status, immunocompetence, lung cancer stage, histotype and the occurrence of respiratory infections. The patients (81 males, 15 females) had a mean age of 64 +/- 9 years. Of these, 62 were smokers, 30 were ex-smokers and four had never smoked. Sixty-seven patients had a prior history of chronic bronchitis. A total of 42 micro-organisms were cultured from the BAL fluids of 33 patients (34.3%). Fifty percent of these micro-organisms were gram-negative, 33.3% were gram-positive and the remaining 16.7% were other micro-organisms. The bacilli most often isolated were the Haemophilus species, accounting for 38.8% of all gram-negative bacilli. The most frequently isolated gram-positive pathogen was the Staphylococcus aureus. We have not found a significant relationship between the presence of a respiratory infection and the different cell types separately analyzed, nor with SCLC and NSCLC patient groups, nor with the stage of the disease. The performance status, the immunoregulatory ratio and the lymphocyte subsets were not significantly different in patients with or without a pulmonary infection. We think that the identification of a definite etiologic agent is of great importance for a rational anti-microbial treatment of pulmonary infections.

Entities:  

Mesh:

Year:  1994        PMID: 7812701     DOI: 10.1016/0169-5002(94)90544-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.

Authors:  Dan Qiao; Zhiyu Wang; Yaohong Lu; Xiaoting Wen; Hongtao Li; Hui Zhao
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

2.  The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.

Authors:  Matthew Koslow; Gali Epstein Shochet; Alona Matveychuk; Lilach Israeli-Shani; Alexander Guber; David Shitrit
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis.

Authors:  Katja Hattar; Katharina Franz; Michael Ludwig; Ulf Sibelius; Jochen Wilhelm; Jürgen Lohmeyer; Rajkumar Savai; Florentine S B Subtil; Gabriele Dahlem; Bastian Eul; Werner Seeger; Friedrich Grimminger; Ulrich Grandel
Journal:  Cancer Immunol Immunother       Date:  2014-09-04       Impact factor: 6.968

4.  Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines.

Authors:  Mira Y Gökyildirim; Ulrich Grandel; Katja Hattar; Gabriele Dahlem; Elena Schuetz; Florian H Leinberger; Fabian Eberle; Ulf Sibelius; Friedrich Grimminger; Werner Seeger; Rita Engenhart-Cabillic; Ekkehard Dikomey; Florentine S B Subtil
Journal:  Oncotarget       Date:  2018-06-22

5.  Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients.

Authors:  Baykal Tulek; Habibe Koylu; Fikret Kanat; Ugur Arslan; Faruk Ozer
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

6.  Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancer.

Authors:  Nilüfer Avcı; Mustafa Hartavi; Turgut Kaçan; Murat Bayındır; Mustafa Avcı; Cüneyt Özakın; Aynur Engin; Adem Deliqönüll; Turkkan Evrensel; Halis Akalın
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16

7.  Characterising the impact of pneumonia on outcome in non-small cell lung cancer: identifying preventative strategies.

Authors:  Akshay J Patel; Peter Nightingale; Babu Naidu; Mark T Drayson; Gary W Middleton; Alex Richter
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

8.  Alpha1-antitrypsin protects lung cancer cells from staurosporine-induced apoptosis: the role of bacterial lipopolysaccharide.

Authors:  Natalie Schwarz; Srinu Tumpara; Sabine Wrenger; Evrim Ercetin; Jürg Hamacher; Tobias Welte; Sabina Janciauskiene
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.